Larvol Delta - CalciMedica-Announces-that-FDA-Has-Strongly-Recommended-Moving-to-a-Blinded-Placebocontrolled-Trial-with-Auxora-in-Patients-with-Severe-COVID19-Pneumonia

Auxora (CM4620) - CalciMedica

http://www.globenewswire.com/news-release/2020/05/21/2036994/0/en/CalciMedica-Announces-that-FDA-Has-Strongly-Recommended-Moving-to-a-Blinded-Placebo-controlled-Trial-with-Auxora-in-Patients-with-Severe-COVID-19-Pneumonia.html

May 21, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next